- ST Pharm signed a contract totaling $9.19 million to supply MRI contrast medium, Gadovist (gadobutrol), a generic raw material medicine, with a global biopharmaceutical company in Europe.

- The supply deadline is July 3.

- ST Pharm predicted the supply request would increase in the future. Accordingly, it is also expected that the supply contract will double next year and triple in 2025.

[News Link]